Chapter 5 – Alcohols, Aldehydes, and Ketones

[1]  D. E. Carter,et al.  Isolation and identification of the polar metabolites of chlorpheniramine in the dog. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[2]  R. Billings,et al.  The stereoselective enzymic reduction of the synthetic 9-ketocannabinoid, nabilone, in vivo, in isolated liver cells and in liver homogenate. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  T. Ogiso,et al.  The effect of a carboxyl substituent on the metabolism in vitro of certain aromatic aldehydes. , 1979, Xenobiotica; the fate of foreign compounds in biological systems.

[4]  K. Leibman,et al.  Microsomal metabolism of cyclohexene. Hydroxylation in the allylic position. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[5]  T. Walle,et al.  O-methylated catechol-like metabolites of propranolol in man. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[6]  R. Billings,et al.  The metabolism of drugs in isolated rat hepatocytes. A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[7]  Y. Shiobara The effect of carboxyl substituent on the metabolism of aromatic aldehydes. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  R. L. Felsted,et al.  Rat liver aldehyde reductase. , 1977, Biochemical pharmacology.

[9]  N. Bachur Cytoplasmic aldo-keto reductases: a class of drug metabolizing enzymes. , 1976, Science.

[10]  E Solheim,et al.  The metabolism of zingerone, a pungent principle of ginger. , 1976, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  R. Mcmahon,et al.  Reaction pathways of in vivo stereoselective conversion of ethylbenzene to (-)-mandelic acid. , 1976, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  S. Lan,et al.  Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[13]  H. Eklund,et al.  3 Alcohol Dehydrogenases , 1975 .

[14]  J. Meyer,et al.  Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys. , 1973, The Journal of pharmacology and experimental therapeutics.

[15]  D. Morton,et al.  Antiparasitic nitroimidazoles. 6. The metabolism and excretion of some 2-styryl-5-nitroimidazoles. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[16]  W. Trager,et al.  Absolute configurations of the four warfarin alcohols. , 1972, Journal of medicinal chemistry.

[17]  K. Tipton,et al.  The characterization of two reduced nicotinamide-adenine dinucleotide phosphate-linked aldehyde reductases from pig brain. , 1972, The Biochemical journal.

[18]  R. T. Williams,et al.  The metabolism of ( 35 S) homosulphanilamide in the rat, rabbit, guinea pig and monkey. , 1972, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  F. Di Carlo,et al.  Bunolol metabolism by cell-free preparations of human liver: biosynthesis of dihydrobunolol. , 1972, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  R. Waring,et al.  The metabolism of alicyclic ketones in the rabbit and rat. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  R. Billings,et al.  The dehydrogenation of 1-indanol by a soluble oxidoreductase from bovine liver. , 1971, The Journal of biological chemistry.

[22]  R. Mcmahon Enzymatic Oxidation and Reduction of Alcohols, Aldehydes and Ketones , 1971 .

[23]  K. Leibman Reduction of ketones in liver cytosol. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  R. Billings,et al.  The fate of an experimental MAO inhibitor, N-cyclopropyl-2-chlorophenoxyethylamine (Lilly 51641) in the rat and in man. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  T. Elliott,et al.  The in vitro and in vivo metabolism of optically active methylcyclohexanols and methylcyclohexanones , 1969, The Journal of pharmacy and pharmacology.

[26]  R. Hermann,et al.  Structure-activity relationships among substrates for a rabbit kidney reductase. Quantum chemical calculation of substituent parameters. , 1969, Journal of medicinal chemistry.

[27]  T. Chase,et al.  Metabolism of some phenylethylamines and their beta-hydroxylated analogs in brain. , 1969, The Journal of pharmacology and experimental therapeutics.

[28]  R. Mcmahon,et al.  Reductase for aromatic aldehydes and ketones. The partial purification and properties of a reduced triphosphopyridine nucleotide-dependent reductase from rabbit kidney cortex. , 1968, The Journal of biological chemistry.

[29]  W. Stoffel,et al.  Metabolism of Sphingosine Bases, VIII. Distribution, Isolation and Properties of D-3-Oxosphinganine Reductase. Stereospecificity of the NADPH-dependent Reduction Reaction of 3-Oxodihydrosphingosine(2-Amino-1-hydroxyoctadecane-3-one) , 1968 .

[30]  T. Elliott,et al.  The metabolism of the isomeric tert.-butylcyclohexanones. , 1967, The Biochemical journal.

[31]  H. Ringold,et al.  Adamantanone as a probe for the dimensions and characteristics of the substrate binding pocket of certain alcohol dehydrogenases. , 1967, Biochemical and biophysical research communications.

[32]  M. T. Bush,et al.  Metabolic fate of drugs: barbiturates and closely related compounds. , 1967, Annual review of pharmacology.

[33]  R. Mcmahon,et al.  Metabolism of oral cephalothin and related cephalosporins in the rat. , 1967, The Biochemical journal.

[34]  P. Bond Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking Agent , 1967, Nature.

[35]  R. T. Williams,et al.  The metabolism of the isomeric decalones. , 1966, The Biochemical journal.

[36]  H. Ringold,et al.  Experimental strategy for delineation of the enzyme region involved in substrate recognition. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Vladimir Prelog,et al.  Specification of Molecular Chirality , 1966 .

[38]  H. Ringold,et al.  Stereochemical aspects of the substrate specificity of horse liver alcohol dehydrogenase. , 1965, Biochemistry.

[39]  R. Mcmahon,et al.  The nature of the metabolites of acetohexamide in the rat and in the human. , 1965, The Journal of pharmacology and experimental therapeutics.

[40]  R. T. Williams,et al.  STEREOCHEMICAL ASPECTS OF THE METABOLISM OF THE ISOMERIC METHYLCYCLOHEXANOLS AND METHYLCYCLOHEXANONES. , 1965, The Biochemical journal.

[41]  V. Prelog,et al.  Reaktionen mit Mikroorganismen. 14. Mitteilung [1] Reduktion von stereoisomeren Dekalonen‐(1) und einigen verwandten bicyclischen und tricyclischen Ketonen durch Curvularia falcata , 1965 .

[42]  V. Prelog Specification of the stereospecificity of some oxido-reductases by diamond lattice sections , 1964 .

[43]  D. Keglević,et al.  5-Hydroxytryptophol: a metabolite of 5-hydroxytryptamine in rats. , 1962, The Biochemical journal.

[44]  G. Ryback,et al.  Stereochemistry of enzymic hydrogen transfer to pyridine nucleotides. , 1962, Biochemical and biophysical research communications.

[45]  J. Axelrod,et al.  3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine. , 1959, Biochimica et biophysica acta.

[46]  H. F. Fisher,et al.  THE ENZYMATIC TRANSFER OF HYDROGEN FROM ALCOHOL TO DPN , 1951 .